Subtype
Malignant Large Intestinal Neoplasm
CI-CAN-00003173Explore in graph →
1,622 active trials21 approved drugs383 evidence items
- NCIt
- C215202
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003173Explore in graph →
Clinical trials
7,500 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (742)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00337389 | Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. | unknown | Phase 3 | 1,200 | Mast Therapeutics, Inc.INDUSTRY | 2 | Nov 19, 2007 | clinicaltrials |
| NCT00316745 | IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer | suspended | Phase 3 | 200 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | Nov 1, 2007 | clinicaltrials |
| NCT00294359 | The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer | completed | Phase 2 / Phase 3 | 333 | Australasian Gastro-Intestinal Trials GroupNETWORK | 2 | Aug 22, 2007 | clinicaltrials |
| NCT00164879 | Endolaparoscopic Versus Immediate Surgery for Obstructing Colorectal Cancers | unknown | Phase 3 | 70 | Chinese University of Hong KongOTHER | 1 | Aug 7, 2007 | clinicaltrials |
| NCT00272051 | XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy | completed | Phase 3 | 620 | SanofiINDUSTRY | 0 | Sep 13, 2006 | clinicaltrials |
| NCT00309530 | Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C | completed | Phase 3 | 598 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Apr 3, 2006 | clinicaltrials |
| NCT00309543 | Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B | completed | Phase 3 | 636 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Apr 3, 2006 | clinicaltrials |
| NCT00154752 | Concurrent Chemoradiation Versus Wide Pelvic Lymphadenectomy for Advanced Rectal Cancer | unknown | Phase 3 | 200 | National Taiwan University HospitalOTHER | 1 | Nov 22, 2005 | clinicaltrials |
| NCT00212589 | Patients Preference for Oral or i.v. Therapy | completed | Phase 3 | 60 | Odense University HospitalOTHER | 1 | Sep 21, 2005 | clinicaltrials |
| NCT00189657 | 5FU/VL Vs LV5FU2 + CPT11 in Stage II-III Resected Rectal Cancer | unknown | Phase 3 | — | Association Européenne de Recherche en OncologieOTHER | 1 | Sep 19, 2005 | clinicaltrials |
| NCT00189683 | Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy | unknown | Phase 3 | — | Association Européenne de Recherche en OncologieOTHER | 1 | Sep 19, 2005 | clinicaltrials |
| NCT00119899 | Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases | completed | Phase 3 | 150 | Radboud University Medical CenterOTHER | 1 | Aug 31, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Nov 19, 2007source: clinicaltrials